Literature DB >> 17030572

The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in macrophages and inhibits the host immune response.

Sherry Kurtz1, Karen P McKinnon, Marschall S Runge, Jenny P-Y Ting, Miriam Braunstein.   

Abstract

The SecA protein is present in all bacteria, and it is a central component of the general Sec-dependent protein export pathway. An unusual property of Mycobacterium tuberculosis is the presence of two SecA proteins: SecA1, the essential "housekeeping" SecA, and SecA2, the accessory secretion factor. Here, we report that a DeltasecA2 mutant of M. tuberculosis was defective for growth in the early stages of low-dose aerosol infection of C57BL/6 mice, a time during which the bacillus is primarily replicating in macrophages. Consistent with this in vivo phenotype, we found that the DeltasecA2 mutant was defective for growth in macrophages from C57BL/6 mice. The DeltasecA2 mutant was also attenuated for growth in macrophages from phox(-/-) mice and from NOS2(-/-) mice. These mice are defective in the reactive oxygen intermediate (ROI)-generating phagocyte oxidase and the reactive nitrogen intermediate (RNI)-generating inducible nitric oxide synthase, respectively. This indicated a role for SecA2 in the intracellular growth of M. tuberculosis that is independent of protecting against these ROIs or RNIs. Macrophages infected with the DeltasecA2 mutant produced higher levels of tumor necrosis factor alpha, interleukin-6, RNI, and gamma interferon-induced major histocompatibility complex class II. This demonstrated a function for M. tuberculosis SecA2 in suppressing macrophage immune responses, which could explain the role of SecA2 in intracellular growth. Our results provide another example of a relationship between M. tuberculosis virulence and inhibition of the host immune response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030572      PMCID: PMC1698048          DOI: 10.1128/IAI.01022-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  71 in total

Review 1.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Mycobacterium tuberculosis KatG is a peroxynitritase.

Authors:  N L Wengenack; M P Jensen; F Rusnak; M K Stern
Journal:  Biochem Biophys Res Commun       Date:  1999-03-24       Impact factor: 3.575

3.  Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst.

Authors:  D L Piddington; F C Fang; T Laessig; A M Cooper; I M Orme; N A Buchmeier
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.

Authors:  E H Noss; R K Pai; T J Sellati; J D Radolf; J Belisle; D T Golenbock; W H Boom; C V Harding
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

5.  Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro.

Authors:  C Manca; S Paul; C E Barry; V H Freedman; G Kaplan
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

6.  Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions.

Authors:  R F Silver; Q Li; J J Ellner
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

7.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

8.  Tumor necrosis factor alpha (TNFalpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNFalpha from iron-treated infected monocytes.

Authors:  T F Byrd
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

9.  Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase.

Authors:  M A De Groote; U A Ochsner; M U Shiloh; C Nathan; J M McCord; M C Dinauer; S J Libby; A Vazquez-Torres; Y Xu; F C Fang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

10.  Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha.

Authors:  M K Balcewicz-Sablinska; J Keane; H Kornfeld; H G Remold
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

View more
  48 in total

Review 1.  Protein export systems of Mycobacterium tuberculosis: novel targets for drug development?

Authors:  Meghan E Feltcher; Jonathan Tabb Sullivan; Miriam Braunstein
Journal:  Future Microbiol       Date:  2010-10       Impact factor: 3.165

2.  An orphaned Mce-associated membrane protein of Mycobacterium tuberculosis is a virulence factor that stabilizes Mce transporters.

Authors:  Ellen Foot Perkowski; Brittany K Miller; Jessica R McCann; Jonathan Tabb Sullivan; Seidu Malik; Irving Coy Allen; Virginia Godfrey; Jennifer D Hayden; Miriam Braunstein
Journal:  Mol Microbiol       Date:  2016-02-05       Impact factor: 3.501

3.  Structural Similarities and Differences between Two Functionally Distinct SecA Proteins, Mycobacterium tuberculosis SecA1 and SecA2.

Authors:  Stephanie Swanson; Thomas R Ioerger; Nathan W Rigel; Brittany K Miller; Miriam Braunstein; James C Sacchettini
Journal:  J Bacteriol       Date:  2015-12-14       Impact factor: 3.490

4.  Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis.

Authors:  Joseph Hinchey; Sunhee Lee; Bo Y Jeon; Randall J Basaraba; Manjunatha M Venkataswamy; Bing Chen; John Chan; Miriam Braunstein; Ian M Orme; Steven C Derrick; Sheldon L Morris; William R Jacobs; Steven A Porcelli
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 5.  Molecular mechanisms of host-pathogen interactions and their potential for the discovery of new drug targets.

Authors:  Volker Briken
Journal:  Curr Drug Targets       Date:  2008-02       Impact factor: 3.465

6.  Label-free Quantitative Proteomics Reveals a Role for the Mycobacterium tuberculosis SecA2 Pathway in Exporting Solute Binding Proteins and Mce Transporters to the Cell Wall.

Authors:  Meghan E Feltcher; Harsha P Gunawardena; Katelyn E Zulauf; Seidu Malik; Jennifer E Griffin; Christopher M Sassetti; Xian Chen; Miriam Braunstein
Journal:  Mol Cell Proteomics       Date:  2015-03-26       Impact factor: 5.911

7.  Immunological diversity within a family of cutinase-like proteins of Mycobacterium tuberculosis.

Authors:  Nicholas P West; Teresa M Wozniak; Jesus Valenzuela; Carl G Feng; Alan Sher; Jose M C Ribeiro; Warwick J Britton
Journal:  Vaccine       Date:  2008-05-23       Impact factor: 3.641

8.  Contrasting transcriptional responses of a virulent and an attenuated strain of Mycobacterium tuberculosis infecting macrophages.

Authors:  Alice H Li; Simon J Waddell; Jason Hinds; Chad A Malloff; Manjeet Bains; Robert E Hancock; Wan L Lam; Philip D Butcher; Richard W Stokes
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

9.  Direct EPR Detection of Nitric Oxide in Mice Infected with the Pathogenic Mycobacterium Mycobacterium tuberculosis.

Authors:  Anatoly F Vanin; Raisa P Selitskaya; Vladimir A Serezhenkov; Galina N Mozhokina
Journal:  Appl Magn Reson       Date:  2009-12-03       Impact factor: 0.831

10.  The genome of a Bacillus isolate causing anthrax in chimpanzees combines chromosomal properties of B. cereus with B. anthracis virulence plasmids.

Authors:  Silke R Klee; Elzbieta B Brzuszkiewicz; Herbert Nattermann; Holger Brüggemann; Susann Dupke; Antje Wollherr; Tatjana Franz; Georg Pauli; Bernd Appel; Wolfgang Liebl; Emmanuel Couacy-Hymann; Christophe Boesch; Frauke-Dorothee Meyer; Fabian H Leendertz; Heinz Ellerbrok; Gerhard Gottschalk; Roland Grunow; Heiko Liesegang
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.